RxDoctor Payments Data

Ronald Nave, PA

Medical · Norfolk, VANPI 1649345372

Payments from drug & device makers

$2,036in general payments, 2019–2025

Across 88 payments — averaging $23.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$808
  • Medtronic$310
  • Almatica Pharma LLC$267
  • Azurity Pharmaceuticals, Inc.$170
  • Arbor Pharmaceuticals, Inc.$97
  • Bioventus LLC$43
  • plus $340 from 13 others

What the payments were for

  • Food & beverage$2,02499%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,036 in reported general payments places this provider in the 75th percentile of 632 medical providers in Virginia.

See all medical providers in Virginia

Medicare billing

Part B allowed, 2024
$86,873
Medicare patients
412
Services billed
3,063

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen484$12,472
LyricaPregabalin11$9,994
OxycontinOxycodone Hcl12$9,417
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen341$9,047
Xtampza ErOxycodone Myristate12$6,655
Gabapentin460$5,790
Fentanyl21$2,852
Pregabalin129$2,588
Oxycodone Hcl121$1,773
Tramadol Hcl200$1,511
Tizanidine Hcl24$442
Duloxetine Hcl32$401
Topiramate21$144
Acetaminophen-CodeineAcetaminophen With Codeine17$142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerLyrica$31$9,99411 claims
Collegium Pharmaceutical, Inc.Xtampza Er$22$6,65512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 632 medical providers in Virginia.

Other medical in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →